FDA Inspection 1314884 - Dr. Nagaraju Boyilla, M.D. - March 28, 2026

Record Details

This FDA Inspection record concerns Dr. Nagaraju Boyilla, M.D., with an inspection on March 28, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Dr. Nagaraju Boyilla, M.D.
Inspection Date: March 28, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Alanna L. Mussawwir Bias
Alanna L. Mussawwir-Bias (Investigator)

View Company Profile

ID · ed217193-7626-4af9-bd35-d4bacd98d341

Inspection Facts

Inspection number: 1314884
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Nagaraju Boyilla, M.D.

FDA Inspection

Dr. Nagaraju Boyilla, M.D.March 28, 2026

FDA Inspection 1314884 - Dr. Nagaraju Boyilla, M.D. - March 28, 2026

Record Details

This FDA Inspection record concerns Dr. Nagaraju Boyilla, M.D., with an inspection on March 28, 2026, issued by the Office of Inspections and Investigations, covering human drugs.